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The early repolarization (ER) pattern on the 12-lead electrocardiogram is characterized
by J point elevation in the inferior and/or lateral leads. The ER pattern is associated with
an increased risk of ventricular arrhythmias and sudden cardiac death (SCD). Based
on studies in animal models and genetic studies, it has been proposed that J point
elevation in ER is a manifestation of augmented dispersion of repolarization which creates
a substrate for ventricular arrhythmia. A competing theory regarding early repolarization
syndrome (ERS) proposes that the syndrome arises as a consequence of abnormal
depolarization. In recent years, multiple clinical studies have described the characteristics
of ER patients with VF in more detail. The majority of these studies have provided
evidence to support basic science observations. However, not all clinical observations
correlate with basic science findings. This review will provide an overview of basic
science and genetic research in ER and correlate basic science evidence with the clinical
phenotype.
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INTRODUCTION
The early repolarization pattern (ER) on the 12-lead electrocardiogram (ECG) is characterized by
elevation of the J point in the inferior and/or lateral leads. The J point refers to the junction between
the end of the QRS complex and the start of the ST segment. Elevation of the J point typically
manifests as a slurring or notching of the terminal part of the QRS complex. Over the years the
description of the ER pattern has varied significantly. Based on the most recent expert consensus,
in order for ER to be present, the following criteria have to be met; (1) end-QRS notch or slur on the
downslope of a prominent R-wave, (2) J point is≥0.1mV in 2 or more contiguous leads, excluding
leads V1–V3, and (3) QRS duration is <120ms (MacFarlane et al., 2015; Figure 1).
The ER pattern is frequently observed in the general population, with a reported prevalence
of 2–31% (Merchant et al., 2009; Maury and Rollin, 2013) but is probably closer to 5–10%.
For decades, ER was regarded as a benign ECG variant in healthy populations (Goldman, 1953;
Wasserburger and Alt, 1961). However, in recent years accumulating evidence has challenged this
view. Multiple case-control and population-based studies have demonstrated that ER is associated
with an increased risk of ventricular fibrillation (VF) and sudden cardiac death (SCD; Otto et al.,
1984; Garg et al., 1998; Kalla et al., 2000; Horigome et al., 2003; Takeuchi et al., 2003; Haïssaguerre
et al., 2008; Sinner et al., 2010; Derval et al., 2011; Haruta et al., 2011; Olson et al., 2011; Rollin
et al., 2012; Rosso et al., 2012; Aizawa et al., 2013; Wu et al., 2013). It is important to emphasize
however, that ER is common in the general population, and only a small subset of patients
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FIGURE 1 | ER pattern on the surface ECG. The examples illustrate an end-QRS notch (left) and slur (right) on the downslope of a prominent R-wave. Current
criteria for a diagnosis of ER include; (1) end-QRS notch or slur on the downslope of a prominent R-wave, (2) J point is ≥0.1mV in 2 or more contiguous leads,
excluding leads V1–V3, and (3) QRS duration is <120ms (Figure 1; MacFarlane et al., 2015).
with the ECGpattern have an increased risk of SCD. The reported
association between ER pattern and VF in these studies has led
to the acknowledgment of a clinical syndrome, labeled the early
repolarization syndrome (ERS).
The emergence of reports linking ER and SCD has led to
significant interest into the pathophysiological basis of the ECG
pattern. An in-depth understanding of the mechanistic link
between ER and ventricular arrhythmogenesis is likely to have
important implications for risk stratification and potentially
therapy. This review will provide an overview of mechanistic and
genetic research in ERS and correlate basic scientific observations
with the clinical phenotype.
BASIC STUDIES IN ANIMAL MODELS AND
THE REPOLARIZATION THEORY
The first studies exploring the mechanistic basis of J point
elevation on the ECG emerged in the 1950’s (Osborn, 1953).
Osborn reported the appearance of J point elevation secondary
to severe hypothermia and acidosis in a canine model. Although
it was unclear which of the two factors caused the ECG change, he
speculated that the appearance of J waves (in lead II of the surface
ECG) represented a “current of injury.” J point elevation was
consistently associated with VF in the hypothermic dogs. Santos
et al subsequently reported inferior J point elevation (also in lead
II) in hypothermic dogs; see Figure 2. However, J point elevation
was not associated with acidosis and the authors concluded that
the pattern was induced by hypothermia (Santos and Kittle,
1958).
In order to correlate the appearance of J waves on the ECG
with the ventricular action potential (AP), West et al performed
a series of experiments in anesthetized open-chest dogs. They
demonstrated that induced hypothermia resulted in J point
elevation in ECG lead II with a progressively more pronounced
phase 1 “notch” of the ventricular AP. The magnitude of J
point elevation was directly proportional with the magnitude
of the notch. Furthermore, the AP notch and J point elevation
were rate dependent, with more pronounced changes at slower
heart rates (West et al., 1959). Based on the observed response
of the notch to changing heart rates, the authors argued
that J point elevation was unlikely to represent a “current of
injury.”
A more in-depth insight into the mechanistic basis of
J point elevation came almost four decades later from an
elegant series of experiments from Antzelevitch et al. (Yan and
Antzelevitch, 1996). In an ex vivo model of arterially perfused
canine left and right ventricular wedges, they simultaneously
recorded transmural ECGs and endocardial, epicardial, and mid-
myocardial APs and correlated J waves with transmural AP
characteristics (Yan and Antzelevitch, 1996). Consistent with
the observations from West et al. hypothermia simultaneously
resulted in an increase in the J wave amplitude and a
more prominent phase 1 notch in the epicardial AP but
not the endocardial AP. They also demonstrated that direct
pharmacological inhibition of the Ito current with 4-AP resulted
in a reduction in the epicardial AP notch and corresponding
reduction in the magnitude of the J wave. Furthermore, pacing
the ventricular wedges with progressively more premature
stimuli resulted in a progressive reduction in the amplitude of
the J wave as well as the epicardial phase 1 AP notch. The
observation that shortening the pacing cycle length attenuated
the J wave in the transmural ECG was attributed to a
progressively slower recovery of the Ito current at shorter
cycle lengths. These observations suggest that a J wave is a
manifestation of a transmural voltage gradient created by a more
prominent epicardial AP notch relative to the endocardial AP
notch. Furthermore, the Ito current is an important mediator
of the transmural heterogeneity of the phase 1 notch. Overall
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FIGURE 2 | Electrocardiographic changes from early studies in a dog
with experimental hypothermia. Progressively lower temperatures
(centigrade) were observed to be associated with more pronounced J point
elevation with a notch in the terminal portion of the QRS complex. Reproduced
with permission (Santos and Kittle, 1958).
the findings from these experiments form the basis of the
repolarization theory for ERS.
Antzelevitch and colleagues have also provided valuable
insights into the potential mechanisms of ventricular arrhythmia
in ERS. Using the aforementioned canine model, with ventricular
wedges from the inferior and lateral wall, they pharmacologically
modeled ERS using a combination of Ito and IK-ATP agonists
and ICa and INa antagonists. These ionic currents were targeted
based on evidence from the above studies as well genetic
studies in ERS (discussed in subsequent sections). The authors
demonstrated marked epicardial dispersion of repolarization
in the ERS model, with a loss of the phase 2 AP dome
and AP shortening in some epicardial regions but not others.
Heterogeneous repolarization allowed propagation of the AP
dome, resulting in local re-excitation, whichmanifested as closely
coupled extrasystolic activity (phase 2 re-entry). The interaction
between triggering extrasystoles and a ventricular substrate with
marked repolarization heterogeneity resulted in VF (Koncz et al.,
2014). See Figure 3 for a schema demonstrating phase 2 re-
entry. The study also investigated the effects of vagal modulation
FIGURE 3 | Schema demonstrating phase 2 reentry. Accentuation of the
phase 1 notch of the AP is seen in a heterogenous manner across epicardial
sites. This leads to an exaggerated phase 1 notch and phase 2 dome at point
(A), whereas the phase 1 notch is accentuated to such an extent that the area
is repolarised at point (C), resulting in the loss of the phase 2 dome. This area
is no longer refractory and therefore allows the phase 2 dome at point (B) to
be conducted to epicardial site (C). This results in extra systolic activity that
manifests on the ECG as an R-on-T premature ventricular complex (PVC). This
closely-coupled PVC initiates circus re-entry and PMVT/VF. The dispersion of
the phase 1 notch manifests as J point elevation on the surface ECG.
and pharmacological therapy on arrhythmia susceptibility and
described differences in arrhythmia susceptibility in the inferior
and lateral left ventricle (discussed in detail in subsequent
sections).
PARALLELS WITH BRUGADA SYNDROME
AND THE DEPOLARIZATION THEORY
Based on the above studies in animal models, ERS has widely
been regarded as a repolarization abnormality, with J point
elevation attributed to regional differences in the phase 1
AP notch. It is important to emphasize however that there
remains controversy regarding the mechanistic basis of ERS.
A competing theory proposes that ERS is a manifestation of a
depolarization abnormality. The depolarization theory for ERS
is largely based on parallels drawn with Brugada syndrome (BrS).
BrS is characterized by J point elevation in the right precordial
leads. Based on the clinical overlap between BrS and ERS, it
has been proposed that BrS is a right ventricular variant of ERS
(Benito et al., 2008; Haïssaguerre et al., 2008; Belhassen et al.,
2009; Haïssaguerre et al., 2009b).
The mechanistic basis of BrS is also a subject of debate
and the question regarding whether it is a repolarization
abnormality or a depolarization abnormality remains unresolved
(Meregalli et al., 2005). Indeed, uncertainty remains as to
whether BrS is a primary channelopathy, a structural cardiac
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disease, or a combination of the two (Hoogendijk et al.,
2010). The argument supporting BrS as a channelopathy is
based on the identification of sodium channel mutations in
BrS patients. However, it has been noted that such mutations
are only present in ∼20% of patients with BrS and the
cause and effect of such mutations is not clear (Crotti
et al., 2012). Some authors have therefore suggested that
classifying BrS as a channelopathy is premature (Coronel et al.,
2006). The argument supporting a structural cardiac disease
is based on the identification right ventricular fibrosis and
fatty infiltration, and wall motion abnormalities in BrS patients
(Takagi et al., 2001; Frustaci et al., 2005; Zumhagen et al.,
2009).
The depolarization theory for BrS proposes that a delay in
activation in the right ventricular outflow tract (RVOT) results
in a “current-to-load” mismatch, which manifests as J point and
ST segment elevation (Hoogendijk et al., 2013). Evidence to
support this theory is predominantly based on identification of
fractionated electrograms and conduction slowing in the RVOT
of BrS patients (Postema et al., 2008; Lambiase et al., 2009; Sacher
et al., 2014). Studies in animal models have also demonstrated
that sodium channel blockade results in excitation failure,
manifesting as a BrS-type ST segment elevation (Hoogendijk
et al., 2011). Based on computer modeling, it has been proposed
that the Ito and ICaL currents play important roles in modulating
excitation failure.
There is a relative paucity of direct evidence to support
the depolarization theory in ERS. In contrast to BrS patients,
structural abnormalities (fibrosis and fatty infiltration), and
conduction slowing (fractionated electrograms) have not been
reported ERS patients. Based on responses to drugs such as
quinidine and isoproterenol and genetic studies (discussed in
the next section), the Ito, ICaL, and INa currents have been
implicated in ERS. Sequential activation of the INa, Ito, and ICaL
play important roles in depolarization and propagation of the
AP(Nerbonne and Kass, 2005). Perturbations in these currents
could therefore result in regional conduction delay and/or
excitation failure in the inferior and lateral walls, resulting in an
ER pattern. It is important to note however, that in contrast to
BrS patients, ERS patients do not display significant ST segment
elevation, which would argue against excitation failure in ERS.
There is some evidence to suggest that conduction slowing
without excitation failure may still lead to J-point elevation
(Coronel et al., 2005). However, conduction slowing has not been
demonstrated in patients with ERS thus far.
GENETIC STUDIES AND IONIC CURRENTS
IMPLICATED IN ERS
Multiple ion channel mutations have been associated with ERS
(Figure 4). The most frequently reported association has been
between the KCNJ8 gene and ERS. KCNJ8 encodes the Kir6.1
subunit of the KATP channel. Haissaguerre et al. reported a
KCNJ8 mutation in a case of ERS and VF storm (Haïssaguerre
et al., 2009a). The same KCNJ8 mutation (S422L) was observed
by Medeiros-Domingo et al. in 2 out of a series of 101
patients with ERS and BrS. Both the affected cases had ERS.
Functional characterization of the mutation revealed a gain-
of-function in the KATP channel (Medeiros-Domingo et al.,
2010). Barajas-Martinez et al. also identified the KCNJ8 S422L
mutation in 4 out of 204 ERS and BrS patients. They reported
that the gain-of-function effect in KATP seen with this mutation
is a consequence of a reduced sensitivity of the channel to
intracellular ATP (Barajas-Martínez et al., 2012). More recently,
mutations in ABCC9, which encodes the ATP-binding cassette
transporter of IK−ATP have been identified in ERS patients. After
screening a cohort of 150 patients with ERS and BrS, Hu et al
identified four ERS patients with ABCC9 mutations (Hu et al.,
2014). Functional analysis revealed that the mutation indirectly
augments the IK−ATP current.
As discussed in the previous section, the Ito current has been
implicated as an important contributor to J wave syndromes
in animal studies. On the basis of these reports, Perrin et al.
performed genetic screening in a cohort of 31 ERS patients and
20 Brugada syndrome patients for mutations in genes encoding
Ito channel subunits (KCNA4, KCND2, and KCND3). They also
screened the KCNJ8 gene. They did not identify mutations in any
patients with infero-lateral ERS. A single mutation in KCND2
(D612N) was identified in a patent with an unusual J wave
syndrome with evidence of QRS notching in the anterior leads.
Functional characterization revealed a gain-of-function effect
with an increased Ito current density.
Mutations in ion channels that encode inward currents
have also been implicated in ERS. Burashnikov and colleagues
reported multiple mutations in L-type calcium channel subunit
genes (CACNA2D1, CACNA1C, and CACNB2) after screening 24
ERS patients (Burashnikov et al., 2010). Preliminary functional
analysis revealed that the mutations are associated with
loss-of-function type modulation (Napolitano and Antzelevitch,
2011). Watanabe et al. identified mutations in the SCN5A gene
in three ER patients after screening a cohort of 26 patients.
Functional studies demonstrated a loss-of-function effect, with
all three mutations failing to generate an INa current (Watanabe
et al., 2011).
The findings from genetic studies are generally consistent
with the repolarization theory for ERS. Although, it should be
noted that only one mutation has been identified in the Ito
channel. The Ito and IK−ATP currents play important roles during
the early phases of the AP and are more abundantly expressed
in the epicardium relative to the endocardium. Therefore,
gain-of-function mutations in Ito and IK−ATP are predicted
to increase the transmural voltage gradient by preferentially
augmenting the epicardial phase 1 notch (Antzelevitch and
Barajas-Martinez, 2010; Benito et al., 2010). Loss-of-function ICa
and INa channel mutations on the other hand are predicted
to reduce depolarizing forces. As a result of higher epicardial
expression of the aforementioned Ito and IK−ATP currents, the
epicardium is more susceptible to the reduction in depolarizing
forces (Meregalli et al., 2005). Therefore, loss-of-function ICa and
INa channel mutations are also predicted to augment transmural
voltage gradients during the early phases of the AP. Overall,
gain-of-function IK−ATP and Ito channel mutations and loss-of-
function ICa and INa channel mutations are predicted to result
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FIGURE 4 | Genetic mutations implicated in patients with ERS. Gain-of-function mutations in KCNJ8 (ERS) and KCND2 (in an atypical J wave syndrome) result
in augmented KATP and Ito currents, respectively. Loss-of-function mutations in CACNA2D1, CACNA1C, and CACNB2 result in an attenuated ICa while SCN5A
mutations are predicted to result in an attenuation of INa.The overall effect is an outward shift in the balance of currents, which is predicted to preferentially accentuate
the epicardial AP notch (red).
in an overall outward shift in the balance of currents, which in
turn is predicted to accentuate the epicardial AP notch Figure 4;
(Koncz et al., 2014; Patocskai et al., 2016). Of note, based on
results from genetic studies, pharmacological augmentation of
IK−ATP and Ito and attenuation of ICa and INa have been used
to recapitulate both the ECG pattern and arrhythmic features of
ERS in a canine ventricular wedge model (Koncz et al., 2014).
The reported genetic mutations may also support the
depolarization theory for ERS. Loss-of-function INa channel
mutations are predicted to directly reduce conduction velocity
by decreasing the AP upslope. Ito and ICa channel mutations also
have the potential to influence conduction velocity by altering the
early phase of the AP (Yan and Antzelevitch, 1999; Hoogendijk
et al., 2011, 2013). Evidence to support this theory has come from
a recent study from Hoogendijk and colleagues. In porcine ex
vivo model, they demonstrated that sodium channel blockade
results in excitation failure and ST elevation on a pseudo ECG.
Furthermore, using computer modeling, they demonstrated
that manipulation of the Ito and ICa channels also influences
current-to-load matching (Hoogendijk et al., 2011). Specifically,
Ito reduced the current available for conduction while, ICaL
had the opposite effect. On the basis of these observations,
it is plausible that the reported mutations influence the ERS
phenotype through altered depolarization.
CLINICAL CORRELATIONS
As discussed in previous sections, the repolarization theory
regarding the mechanistic basis of ERS proposes that J point
elevation is a manifestation of augmented heterogeneity of
the AP notch, which predisposes to phase 2 re-entry and
ventricular arrhythmia. The depolarization theory on the other
hand proposes that J point elevation is a manifestation of delayed
activation of specific regions of the myocardium, a “current-
to-load” mismatch. To date, the evidence in support of the
repolarization theory has been more compelling.
Since the reports of an association between ER and SCD,
multiple clinical studies have described the characteristics of ER
patients who have had VF. The majority of clinical observations
have been correlated with the repolarization theory (Figure 5).
There are however some aspects of the clinical syndrome that
may support the depolarization theory. There also remain some
clinical features of ERS that are unexplained. The correlation
between mechanistic theories and the clinical syndrome is
discussed below.
Dispersion of Repolarization and Phase 2
Re-Entry
In ERS patients with electrical storm, Nam et al. reported a
marked increase in the J wave amplitude prior to the onset
of VF. They also identified closely coupled ventricular
premature beats (VPBs) triggering VF episodes. The
authors recorded the Tpeak-Tend, a marker of repolarization
in these patients and found significant differences in
the Tpeak-Tend between ECG leads around the time of
VF (Nam et al., 2010). These clinical observations are
consistent with increased dispersion of repolarization and
phase 2 re-entry preceding VF episodes, which correlates
with an accentuation of the phase 1 AP notch preceding
phase 2 re-entry in animal models (Patocskai et al.,
2016).
Aizawa and colleagues also reported that patients
with ERS display higher J wave amplitudes preceding
VF episodes. Moreover, they reported pause-dependent
accentuation of J point elevation preceding VF episodes
(Aizawa et al., 2012). These observations are consistent
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FIGURE 5 | Mechanistic links between basic science studies and clinical features in ERS. (A) Basic science studies have demonstrated that J point elevation
is a manifestation of increased transmural repolarization heterogeneity. (B) Patients with an inferior ER pattern have a higher risk of ventricular arrhythmias, which
could potentially be related to increased Ito in the inferior wall. (C) ERS patients demonstrate more pronounced J point elevation immediately preceding VF episodes.
Higher J waves may reflect augmented repolarization heterogeneity. J wave augmentation is pause-dependent, which may, be a reflection of Ito channel kinetics (slow
temporal recovery from activation). The proposed mechanism of VF/PMVT is phase 2 reentry. (D) Isoproterenol suppresses VF/PMVT and reduces J point elevation in
ERS, an effect that is thought to be mediated by elevated heart rates and reduced Ito channel recovery. (E) Quinidine also suppresses VF/PMVT in ERS by blocking
the Ito current. (F) Hypothermia results in an augmented transmural repolarization gradient and an increased susceptibility to VF/PMVT.
with cellular electrophysiology studies demonstrating slow
temporal recovery of the Ito channel from inactivation,
which results in an augmented Ito current at slower
heart rates (Yan and Antzelevitch, 1996). In keeping with
the Ito channel kinetics, administration of acetylcholine
has been reported to increase the phase 1 AP notch
which in turn increases dispersion of repolarization and
susceptibility to VF (Koncz et al., 2014). These data may
also explain why VF is more frequently observed in
patients with ERS during sleep or low levels of activity
(Antzelevitch and Yan, 2015).
Invasive mapping studies in patients with ERS using
monophasic action potential (MAP) catheters have demonstrated
more prominent phase 1 AP notching in the inferior and lateral
left ventricular epicardium (Mahida et al., 2015). These findings
provide direct support for basic science reports demonstrating
that a prominent epicardial phase 1 AP notch underlies J point
elevation (Koncz et al., 2014). Invasive studies have also reported
that amongst patients with an inferior ER pattern, short-coupled
VPBs that potentially trigger VF originate from the inferior
wall of the left ventricle (Haïssaguerre et al., 2008). These
observations are consistent with studies in ex vivo models of
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ERS demonstrating that local re-excitation (phase 2 re-entry)
and closely coupled extrasystolic activity, occurs in regions with
augmented dispersion of repolarization.
Arrhythmic Risk in Inferior vs. Lateral ER
The distribution of J point elevation has been proposed to
influence risk of VF in ERS. Multiple clinical studies have
demonstrated that J point abnormalities in the lateral ECG
leads are associated with the lowest risk of VF whilst J
point abnormalities in the inferior leads and global J point
abnormalities are associated with progressively increasing risk of
VF (Antzelevitch and Yan, 2010). These findings are consistent
with animal studies demonstrating higher levels of Ito in
the inferior wall of canine myocardium and in experimental
conditions that mimic ERS, this region of myocardium is more
vulnerable to VT/VF (Koncz et al., 2014). Further evidence
has come from studies demonstrating a higher expression of
Ito channel subunits in the inferior wall of the canine LV
(Szentadrassy et al., 2005). It should be noted, however, that
although current data offers explanation as to why an inferior
pattern confers a higher risk of VF, they do not explain why an ER
pattern in the lateral leads does not increase risk despite J point
elevation.
Arrhythmic Risk in Horizontal vs.
Downsloping ST Segments
A horizontal or downsloping morphology of the ST segment has
been reported to be a marker of increased arrhythmic risk in
cohorts of patients with the ER pattern (Tikkanen et al., 2011).
To our knowledge there is no mechanistic data to explain this
phenomenon. There are, however, some parallels that can be
drawn from the BrS. Provocative testing in BrS patients with
class 1c drugs can result in a type 1 ECG, with downsloping ST
segment elevation being characteristic. It could be speculated that
the horizontal/downsloping ST segments observed in ERS are
analogous to those seen in BrS and are therefore representative
of similar cellular and ionic abnormalities. It is important to note
however that this proposed link is speculative; while downsloping
ST segments are occasionally observed in ERS the T wave
inversion observed in BrS are not seen in ERS.
Late Potentials
A relatively high incidence if late potentials (LP) on
signal-averaged ECG (SAECG) has been reported in ERS
patients (Abe et al., 2010). The LP have been reported to
demonstrate dynamic circadian changes, with more pronounced
LP parameters at night time. LP are thought to represent areas
of delayed ventricular conduction. Therefore, the identification
of late potentials in ERS may support the depolarization theory
of ERS. Further evidence to support this notion comes from
studies in BrS patients. Invasive studies in BrS patients have
demonstrated that LP on the SAECG are correlated with
delayed local electrograms recorded during electrophysiology
studies (Nagase et al., 2002). As discussed previously however,
extrapolating results from BrS to ERS should be performed with
caution.
Pharmacological Responses
Quinidine has been demonstrated to suppress VF storm
in patients with ERS (Haïssaguerre et al., 2009a,b).
One of the first reports on the efficacy of quinidine in
ERS came from Haïssaguerre et al. (2009a). In a young
patient with VF storm that was refractory to multiple
antiarrhythmic drugs, only quinidine was effective at
preventing VF. In a subsequent multicentre study, the same
group demonstrated that quinidine effectively suppressed
arrhythmia in 9 out of 9 ERS patients with VF storm
(Haïssaguerre et al., 2009b). Their clinical observations
are in keeping with basic science studies. Quinidine has
consistently been demonstrated to abrogate the ER pattern,
and the associated exaggerated phase 1 notch in in vitro
models of ERS (Koncz et al., 2014; Szél and Antzelevitch,
2014). Quinidine is predicted to exert its antiarrhythmic
effect in ERS patients by suppressing the Ito current
(Antzelevitch and Yan, 2015).
Isoproterenol has been shown to effectively suppresses
electrical storm in ERS patients in multiple studies (Haïssaguerre
et al., 2009a). Furthermore, isoproterenol consistently normalizes
J waves in patients with lateral ERS. In patients with inferior
ERS, the response to beta adrenergic stimulation was more
heterogenous (Roten et al., 2012a). Consistent with these clinical
observations, studies in canine models have demonstrated
that isoproterenol normalizes J point elevation (Yan and
Antzelevitch, 1999). The effect of isoproterenol is likely to be
mediated by a combination of heart rate acceleration, which is
predicted to reduce Ito, and an increase in ICa, that restores
the phase 2 dome and hence transmural AP homogeneity
(Koncz et al., 2014; Patocskai et al., 2016). The distinctive and
heterogenous clinical response of inferior ER to isoproterenol
remains unclear. As discussed previously, Ito expression has
been reported to be higher in the inferior wall (Koncz et al.,
2014). Therefore, isoproterenol would be expected to have
a homogenous effect in inferior ERS patients. A potential
explanation may relate to the fact that the study included
a heterogenous cohort of patients which included patients
with VF, patients with syncope and asymptomatic patients.
Therefore, not all patients in the study had the malignant form
of ERS.
In addition to the reported efficacy of quinidine and
isoproterenol in the aforementioned studies, a number of
antiarrhythmic drugs including beta-blockers, lidocaine,
mexiletine, and verapamil were demonstrated to be ineffective
(Haïssaguerre et al., 2009b). Supporting evidence for these
observations has come from both basic science and genetic
studies. Beta-blockers and verapamil slow the heart rate, which
is predicted to increase Ito channel recovery from inactivation
(Yan and Antzelevitch, 1996). In turn, enhanced Ito channel
recovery increases the phase 1 AP notch and dispersion of
repolarization. In the specific case of verapamil, based on
studies in canine models, calcium channel blockade leads to
a loss of the phase 2 dome of the AP, an effect that is also
predicted to enhance dispersion of repolarization (Fish and
Antzelevitch, 2004). The failure of sodium channel blockers
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such as lidocaine and mexiletine to suppress arrhythmia
in ERS is consistent with the reports of loss-of-function
SCN5A mutations underlying ERS and animal studies
demonstrating that INa blockade with pilsicainide increases
susceptibility to VF (Watanabe et al., 2011; Koncz et al., 2014).
Overall, the observations from basic science studies predict
that beta-blockers, sodium channel blockers, and calcium
channel blockers could actually have a proarrhythmic effect
in ERS.
As discussed previously, ERS demonstrates significant overlap
with BrS, which is typically associated with an accentuated J
wave following administration of the sodium channel blocker
ajmaline (Antzelevitch and Yan, 2015). Based on genetic studies
reporting loss-of-function SCN5A mutations in ERS and basic
science studies demonstrating more prominent AP notching and
J waves following INa blockade, ajmaline would be predicted
to accentuate J waves in ERS patients. Paradoxically however,
a number of studies have reported that ajmaline attenuates J
waves (Kawata et al., 2012; Roten et al., 2012b). Of note, this
response to ajmaline has not been consistent in all studies. A
recent case report involving epicardial left ventricular mapping in
an ERS patient demonstrated that administration of pilsicainide,
an INa blocker, resulted in augmentation of epicardial J waves
in the lateral left ventricle. This change was however not
observed on the surface ECG (Nakagawa et al., 2014). The
mechanisms underlying these discrepant observations remain to
be elucidated.
Hypothermia and VF in ERS
The association between hypothermia and J point elevation
has been recognized for decades. In 1938, Tomaszewski et al.
described a case of a frozen man with J point elevation
(Tomaszewski, 1938). Interestingly, hypothermia has been
reported to increase the risk of ventricular arrhythmias in
patients with ERS. Bastiaenen et al. reported a case of inferior
ER who developed VF storm with more pronounced J point
elevation in response to therapeutic hypothermia (Bastiaenen
et al., 2010). Federman and colleagues reported a case of infero-
lateral ER with hypothermia-induced VF storm (Federman
et al., 2013). The association between hypothermia and J point
elevation is also well established in animal models (Osborn,
1953; Santos and Kittle, 1958; Emslie-smith et al., 1959; West
et al., 1959). In a canine model of ERS, hypothermia has been
reported to accentuate the epicardial AP notch, which results
in a heterogeneous loss of the AP dome, phase 2 re-entry
and VF (Gurabi et al., 2014). Based on the clinical and basic
science findings, it could be speculated that hypothermia acts
as an additional “insult” in ER patients with an underlying
arrhythmogenic substrate.
ER as a Risk Predictor in Coronary Artery
Disease
The ER pattern has been associated with an increased risk
of arrhythmic events in patients with coronary artery disease.
Multiple previous studies have demonstrated that in patients with
acute myocardial infarction, the presence of ER is associated with
a significantly increased of ventricular arrhythmia (Naruse et al.,
2012; Rudic et al., 2012; Tikkanen et al., 2012) ER has also been
associated with an increased risk of ventricular arrhythmia in
patients with chronic coronary artery disease (Patel et al., 2010).
Interestingly, the mechanisms of ventricular arrhythmia in
patients with acute myocardial infarction are thought to be
similar to those in patients with ERS. Yan and colleagues have
previously demonstrated that in an ex vivo right ventricular
wedge preparation, regions of ischaemia had a loss of the
Ito-mediated epicardial AP dome with phase 2 re-entry resulting
in VF (Di Diego and Antzelevitch, 2011; Yan et al., 2004). As
discussed previously, a similar mechanism has been reported by
the same group in an ex vivomodel of ERS. On the basis of these
observations, it could be speculated that ER augments arrhythmic
risk in acute myocardial infarction by increasing risk of phase 2
re-entry (Naruse et al., 2012).
It is important to note that in patients with coronary
artery disease, particularly chronic coronary artery disease, the
presence of J point elevation in the inferior could potentially
be a manifestation of delayed depolarization due to “peri-
infarction block” in areas of scar (Castle, 1965; Littmann,
2010; Tikkanen et al., 2012). Indeed, as discussed previously,
the ER pattern could also potentially be a manifestation of a
depolarization abnormality. Overall, there remains significant
uncertainty regarding the mechanistic links between ER and
increased risk of ventricular arrhythmia in patients with coronary
artery disease.
False Tendons and ER
The ER pattern is more prevalent in patients with false tendons
(Nakagawa et al., 2012). False tendons are fibromuscular bands
containing conduction tissue which traverse the LV cavity
(Luetmer et al., 1986; Abdulla et al., 1990; Loukas et al., 2007). The
mechanistic link between false tendons has yet to be elucidated.
It has been proposed that false tendons may create localized
stretching, which in turn results in repolarization gradients
and J point elevation. An alternative hypothesis is that false
tendons result in altered conduction to the inferior and lateral
walls, leading to J point elevation (Nakagawa et al., 2012). It is
plausible therefore that J point elevation in patients with false
tendons is a manifestation of an intraventricular conduction
defect or repolarization abnormality. However, at this stage, these
proposed mechanisms remain speculative.
FUTURE DIRECTIONS
Despite significant advances in basic science studies, important
gaps remain in our understanding of the mechanistic basis of
ERS. Current mechanistic evidence is based primarily on studies
in an ex vivomodel of ERS, and debate continues with regards the
fundamental mechanistic abnormality that underpins ERS, i.e.,
repolarization or depolarization. While these ex vivo studies have
provided valuable insights, a degree of caution must be exercised
when extrapolating results to a clinical situation. In the future,
more refined basic science and translational studies are necessary
to further our understanding of the mechanistic basis of ERS.
Potential areas of future research are outlined below.
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To date, classical genetic studies in ERS have identified
a small number of ion channel mutations. The mechanistic
link between these mutations and ERS has not been fully
characterized. The recent emergence of next-generation
sequencing technologies such as exome sequencing and whole-
genome sequencing has significantly enhanced our ability to
identify the genetic basis of inherited arrhythmia syndromes.
The application of these technologies in ERS patients is predicted
to identify additional causative mutations. In terms of functional
characterization of the genetic variants, induced pluripotent stem
cell (iPS) technology represents a promising novel technique.
Patient-specific iPS cells have successfully recapitulated the
cellular electrophysiology of a number of inherited arrhythmia
syndromes (Moretti et al., 2010; Itzhaki et al., 2011; Yazawa et al.,
2011). The application of iPS technology in genotype-positive
ERS patients is likely to enhance our understanding of the
mechanistic basis of the trait.
Electrocardiographic imaging ECGI is an emerging
translational research tool for inherited arrhythmia syndromes
(Zhang et al., 2015). The technique involves recording body
surface potentials using 250 body surface electrodes and
computing potentials on the epicardium using the inverse
solution (Rudy and Lindsay, 2015). Information from epicardial
potentials is subsequently used to derive information on
ventricular activation and repolarization. Ghosh et al. recently
utilized ECGI in ERS patients to demonstrate early repolarization
in regions of the LV that corresponded to the ECG leads with
an ER pattern (Ghosh et al., 2010). These regions also had steep
activation recovery interval (ARI) gradients, which are predicted
to promote re-entrant arrhythmias (Ghosh et al., 2010). In the
future, studies in larger numbers of ERS patients with different
ER patterns, e.g., horizontal and downsloping ST segments,
may provide valuable mechanistic information. It is important
to note that while ECGI has demonstrated early promise, it is
associated with significant limitations. For a given set of body
surface potentials, there exist multiple potential cardiac solutions
when the inverse solution is applied. Therefore, assumptions
have to be applied to the analysis. Furthermore, small errors in
the recorded body surface potentials can result in large errors in
the computed epicardial potentials (Rudy and Lindsay, 2015).
To date, the majority of mechanistic studies in ERS have
focused on ion channels and their potential contribution to
abnormal repolarization and/or depolarization. In addition to
ion channels, proteins that mediate cell-to-cell coupling, such
as connections may play important roles in the pathogenesis of
ERS. Interestingly, Nademanee and colleagues demonstrated that
patients with BrS have reduced RVOT expression of connection-
43, which is a major determinant of electrical coupling and
conduction velocity in the ventricle (Nademanee et al., 2015). In
the future, research into connnexin function in patients with ERS
may provide important insights into the mechanistic basis of the
trait.
CONCLUSIONS
Our understanding of the ERS has evolved rapidly in recent years
but significant questions and controversies remain. The body of
basic scientific data from animal and human studies continues to
grow and there is evidence that developing electrophysiological
and imaging technologies are beginning to bridge the gap
between the bench and the bedside. These are important
developments in terms of enhancing risk stratification as well as
developing effective treatment strategies.
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